Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
9.21
+0.03 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
9.40
+0.19 (2.03%)
After-hours: Dec 5, 2025, 7:02 PM EST
Passage Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Passage Bio stock have an average target of 34.5, with a low estimate of 10 and a high estimate of 67. The average target predicts an increase of 274.59% from the current stock price of 9.21.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Passage Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $6 → $21 | Strong Buy | Maintains | $6 → $21 | +128.01% | Nov 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $260 → $67 | Strong Buy | Maintains | $260 → $67 | +627.47% | Aug 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $40 → $10 | Strong Buy | Maintains | $40 → $10 | +8.58% | Aug 14, 2025 |
| Wedbush | Wedbush | Buy Maintains $3 → $40 | Buy | Maintains | $3 → $40 | +334.31% | Aug 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $120 | Strong Buy | Maintains | $120 | +1,202.93% | Jun 24, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-10.05
from -21.44
EPS Next Year
-5.04
from -10.05
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.47 | -3.35 | ||||
| Avg | -10.05 | -5.04 | ||||
| Low | -13.63 | -7.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.